迪哲医药董事长张小林完成减持182.7万股 套现1亿元用于个人资金需求

DoNews
Yesterday

5月8日,迪哲医药(SH688192)披露董事兼高管减持结果公告。公司董事长兼首席执行官张小林通过集中竞价方式累计减持182.7万股,占公司总股本0.4%,减持总金额达1亿元。本次减持计划于2025年4月3日至5月7日实施完毕,减持资金将用于偿还借款等个人用途。减持前,张小林直接持有公司731.1万股(占总股本1.59%),其中部分股份来源于股权激励及二级市场增持。公开资料显示,张小林为迪哲医药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10